Weiss Asset Mgmt Amends Ocean Biomedical Stake

TL;DR

**Weiss Asset Management updated its stake in Ocean Biomedical, showing their latest position as of year-end 2023.**

AI Summary

Weiss Asset Management LP, a Boston-based investment firm, filed an amended Schedule 13G/A on January 26, 2024, indicating a change in their beneficial ownership of Ocean Biomedical, Inc. common stock as of December 31, 2023. This update, an amendment to a previous filing, shows their current stake in the pharmaceutical preparations company. This matters to investors because it provides transparency into a significant institutional holder's position, potentially signaling their ongoing confidence or a shift in their investment strategy in Ocean Biomedical.

Why It Matters

This filing updates the public on a major institutional investor's holdings, which can influence market perception and potentially the stock price of Ocean Biomedical, Inc.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, providing transparency without indicating immediate high risk.

Analyst Insight

Investors should note that a significant institutional investor, Weiss Asset Management LP, has updated its position in Ocean Biomedical, Inc. While this filing doesn't disclose the exact change in share count or percentage, it confirms their continued involvement. Smart investors would look for the specific share count and percentage ownership in the full filing to understand the magnitude of their stake and any changes from previous reports, which could influence their own investment decisions.

Key Players & Entities

• Weiss Asset Management LP (company) — the entity filing the SC 13G/A amendment
• Ocean Biomedical, Inc. (company) — the subject company whose shares are being reported
• December 31, 2023 (date) — the date of the event requiring this filing
• January 26, 2024 (date) — the date the SC 13G/A was filed
• $0.0001 (dollar_amount) — par value per share of Ocean Biomedical common stock

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common stock, par value $0.0001 per share ----------------------------

Filing Documents

• ocea13ga31dec2023.htm (SC 13G/A) — 90KB
• 0001357550-24-000006.txt ( ) — 92KB

IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [X] Investment Adviser registered under section 203 of the Investment Advisers Act or under the laws of any State (f) [ ] Employee Benefit Plan, Pension fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F) (g) [X] A Parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) (h) [ ] A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813) (i) [ ] A Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3) (j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J) CUSIP NO. 67644C104 SCHEDULE 13G/A Page 6 of 2 PAGES

OWNERSHIP

ITEM 4. OWNERSHIP WEISS ASSET MANAGEMENT* (a) Amount Beneficially Owned: 0 ------------------------------------------- (b) Percent of Class: 0.00% ---------------------------------------------------- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 ----------------------- (ii) shared power to vote or to direct the vote: 0 --------------------- (iii) sole power to dispose or to direct the disposition of: 0 ---------- (iv) shared power to dispose or to direct the disposition of: 0 ---------- WAM GP* (a) Amount Beneficially Owned: 0 ------------------------------------------- (b) Percent of Class: 0.00% ---------------------------------------------------- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 ----------------------- (ii) shared power to vote or to direct the vote: 0 --------------------- (iii) sole power to dispose or to direct the disposition of: 0 ---------- (iv) shared power to dispose or to direct the disposition of: 0 ---------- ANDREW M. WEISS, PH.D.* (a) Amount Beneficially Owned: 0 ------------------------------------------- (b) Percent of Class: 0.00% ---------------------------------------------------- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 ------------------------ (ii) shared power to vote or to direct the vote: 0 ----------------------- (iii) sole power to dispose or to direct the disposition of: 0 ----------- (iv) shared power to dispose or to direct the disposition of: 0 ----------- ----------------------- * Weiss Asset Management is the sole investment manager to a private investment partnership, (the "Partnership") and private investment funds ("Funds"). WAM GP is the sole general partner of Weiss Asset Management. Andrew Weiss is the managing member of WAM GP. Shares reported for WAM GP, Andrew Weiss and Weiss Asset Managem

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON See Item 4.

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable

NOTICE OF DISSOLUTION OF GROUP

ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable CUSIP NO. 67644C104 SCHEDULE 13G/A Page 8 of 2 PAGES

CERTIFICATION

ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

MATERIALS TO BE FILED AS EXHIBITS

ITEM 11. MATERIALS TO BE FILED AS EXHIBITS Exhibit 1 Joint Filing Agreement SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct. Dated: January 26, 2024 WEISS ASSET MANAGEMENT LP By: /s/ Mary Ferruolo ----------------------------------- Mary Ferruolo, Authorized Signatory WAM GP LLC By: /s/ Mary Ferruolo ----------------------------------- Mary Ferruolo, Authorized Signatory ANDREW M. WEISS, PH.D. By: /s/ Mary Ferruolo ----------------------------------- Mary Ferruolo, Attorney-in-Fact for Andrew Weiss*** _____ *** Duly authorized under Power of Attorney incorporated herein by reference to the exhibit to the Form 13G/A filed by Weiss Asset Management LP on February 3, 2023 in respect of its holding in DEEP MEDICINE ACQUISITION CORP. CUSIP NO. 67644C104 SCHEDULE 13G/A Page 9 of 2 PAGES Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss, hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13G and/or 13D (including any and all amendments thereto) with respect to the Class A common stock, par value $0.0001 per share of AESTHER HEALTHCARE ACQUISITION CORP., and further agree that this Joint Filing Agreement, as may be amended from time to time, shall be included as an Exhibit to such joint filings. The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and/or 13D and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is ina

View Full Filing

View this SC 13G/A filing on SEC EDGAR